ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

CLRB Cellectar Biosciences Inc

3.40
-0.08 (-2.30%)
Mar 18 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Cellectar Biosciences Inc CLRB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -2.30% 3.40 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.51 3.35 3.51 3.35 3.48
more quote information »

Recent News

Date Time Source Heading
3/18/20248:51IHNWFeaturedElevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
3/18/20248:09IHNWFeaturedProspera Energy Inc. Announces a 508% increase in the 2023 Proven Developed Producing (PDP) Reserve Valuation
3/14/202408:52GLOBECellectar Biosciences to Present at the 36th Annual Roth..
3/04/202406:40GLOBECellectar Biosciences Reports High Rate of Complete..
2/14/202420:31EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/14/202416:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2/07/202406:40GLOBECellectar Biosciences to Present at the Oppenheimer 34th..
2/02/202406:03EDGAR2Form 8-K - Current report
1/31/202408:00EDGAR2Form SC 13G - Statement of acquisition of beneficial..
1/30/202406:40GLOBECellectar Biosciences Announces Enrollment of the First..
1/25/202416:30EDGAR2Form 8-K - Current report
1/25/202406:40GLOBECellectar Biosciences Announces Tranche A Warrants Fully..
1/22/202406:40GLOBECellectar Biosciences Reports Complete Central Nervous..
1/16/202406:40GLOBECellectar Biosciences Broadens Pipeline with Targeted Alpha..
1/12/202406:44GLOBECellectar Biosciences to Host Conference Call with Texas..
1/11/202406:40GLOBECellectar Biosciences Partners with MiBA, a Data Subsidiary..
1/09/202406:02EDGAR2Form 8-K - Current report
1/08/202406:30GLOBECellectar Biosciences Announces Positive Topline Data..
1/03/202408:30GLOBECellectar Biosciences to Announce Top-line Data from WM..
12/19/202308:30GLOBECellectar Biosciences Expands Iopofosine I 131 Collaboration..
12/12/202320:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202320:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202320:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202320:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202308:30GLOBECellectar Biosciences Strengthens Intellectual Property..
12/05/202308:30GLOBECellectar Biosciences to Present at the Targeted..
11/29/202316:31EDGAR2Form 8-K - Current report
11/13/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/02/202307:45EDGAR2Form 8-K - Current report
10/31/202300:15EDGAR2Form EFFECT - Notice of Effectiveness
10/27/202316:40EDGAR2Form 8-K - Current report
10/25/202316:54EDGAR2Form S-3/A - Registration statement under Securities Act of..
10/05/202316:45EDGAR2Form S-3 - Registration statement under Securities Act of..
10/02/202316:40EDGAR2Form DEF 14A - Other definitive proxy statements
9/22/202316:40EDGAR2Form PRE 14A - Other preliminary proxy statements
9/08/202317:17EDGAR2Form 8-K - Current report
8/21/202316:30EDGAR2Form 8-K - Current report
8/14/202308:45EDGAR2Form 8-K - Current report
8/14/202308:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
6/29/202316:31EDGAR2Form 8-K - Current report
6/29/202306:03EDGAR2Form 8-K - Current report
6/28/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/28/202318:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Your Recent History

Delayed Upgrade Clock